MassIVE MSV000097998

Partial Public PXD064324

Early microglia progenitors colonize the embryonic CNS via integrin-mediated transmigration from the pial surface

Description

Microglia progenitors initially colonize the developing central nervous system (CNS) around embryonic day (E) 9.5 in the mouse. Even though their ontogeny from early erythromyeloid progenitors in the yolk sac is well defined, the molecular machinery needed to enter the developing CNS is so far not resolved. Here, we combined unbiased transcriptomic and proteomic approaches to screen for potential factors. We identified a distinct and dynamic integrin expression profile on microglial progenitors, whereas in parallel the developing CNS peaks in the production of extracellular matrix (ECM) molecules. We found that this ECM is deposited along the pial surface between CNS and mesenchyme, where microglial progenitors interact with deposited ECM along the barrier zone of the CNS, pointing to a mesenchyme-to-CNS transmigration route of microglial progenitors. Loss of the integrin adaptor molecule Tln1 in microglia progenitors led to a reduced capacity to enter the developing CNS, whereas their numbers in the surrounding mesenchyme remained unchanged. However, deficiency of Itgb1 or Itgb2 alone was not sufficient to affect this migration. Our data revealed an essential role of a complex integrin expression profile on microglia progenitors to equip these cells to interact with ECM at the pial surface of the developing CNS and facilitate their entrance from the surrounding mesenchyme. [doi:10.25345/C5W08WV50] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: microglia, microglia development, microglia progenitor recruitment, macrophage progenitor migration, integrins ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order)
Prof. Dr. Oliver Schilling, Medical Center - University of Freiburg, Germany
Submitting User: oliver_schilling
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.